Month: June 2023

Clot Management Devices Market Growth 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Clot Management Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global clot management devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the clot management devices market?

Report Attributes Details
Market Size in 2022 US$ 1.7 Billion
Market Forecast in 2028 US$ 2.4 Billion
Growth rate (2023 to 2028) CAGR of 5.58%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is clot management devices?

A blood clot blocks the blood supply to certain parts of the body and can cause severe damage in the long run. However, it can be treated using different clot management devices, such as embolectomy balloon catheters, neurovascular embolectomy devices, catheter-directed thrombolysis (CDT), percutaneous thrombectomy devices and inferior vena cava filters (IVCF). These devices further help in preventing ischemic strokes, severe leg pain and heart attacks.

Request for a free sample copy of this report:https://www.imarcgroup.com/clot-management-devices-market/requestsample

What are the growth prospects and trends in the clot management devicesindustry?

The rising prevalence of cardiovascular diseases (CVDs), along with the growing number of smokers, is increasing the risk of blood clots among individuals. This represents one of the key factors bolstering the clot management devices market growth. Additionally, the escalating demand for minimally invasive (MI) surgeries over open surgeries, is further impelling the market growth. Other than this, some of the leading players in the industry are focusing on introducing technological advancements, which are expected to drive the market in the upcoming years. For instance, Penumbra, Inc., a US-based healthcare company, launched Reperfusion Catheters ACE68, which is a large-bore aspiration catheter designed to navigate tortuous vessels to facilitate extraction of clot quickly.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
    • Mechanical Thrombectomy
    • Aspiration Thrombectomy
    • Percutaneous Mechanical Thrombectomy (PMT)
  • Catheter-Directed Thrombolysis Devices
  • Inferior Vena Cava Filters
    • Permanent
    • Retrievable

Breakup by End-User:

  • Hospitals
  • Diagnostic Centers and Specialty Clinics

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • Boston Scientific Corporation
  • DePuy Synthes Inc.
  • Edwards Lifesciences Corporation
  • iVascular S.L.U.
  • Lemaitre Vascular Inc.
  • Medtronic Inc.
  • Straub Medical AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Vascular Solutions

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2131&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Body Composition Analyzers Market Growth 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Body Composition Analyzers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global body composition analyzers market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the body composition analyzers market?

Report Attributes Details
Market Size in 2022 US$ 716.4 Million
Market Forecast in 2028 US$ 1,149.1 Million
Growth rate (2023 to 2028) CAGR of 8.3%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is body composition analyzers?

A body composition analyzer (BCA) refers to an equipment that provides a snapshot of health by analyzing and differentiating weight, body fat, water percentage, metabolic age, bone mass, muscle mass, and visceral fat rating. It is also used to control the risk of abdominal and truncal obesity. Body composition analyzers can project cumulative variations in the body for a certain amount of time. Bioimpedance analyzer, skinfold calipers, hydrostatic weighing equipment, air displacement plethysmography, and dual-energy x-ray absorptiometry, are some of the common variants of body composition analyzers.

Request for a free sample copy of this report:https://www.imarcgroup.com/body-composition-analyzers-market/requestsample

What are the growth prospects and trends in the body composition analyzers industry?

The rising obese population, due to sedentary consumer lifestyles, unhealthy dietary patterns, and other metabolic disorders, is one of the key factors catalyzing the demand for body composition analyzers. Furthermore, the growing adoption of body composition analyzers in the sports and fitness sector for providing complete body composition assessment of athletes is also driving the market growth. Moreover, the introduction of smarter, lighter, and portable body composition analyzers, integrated with numerous digital technologies, will continue to drive the global market in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Bioimpedance Analyzer
  • Skinfold Calipers
  • Hydrostatic Weighing Equipment
  • Air Displacement Plethysmography
  • Dual Energy X-Ray Absorptiometry
  • Others

Breakup by End User:

  • Hospitals
  • Fitness Clubs and Wellness Centers
  • Academic and Research Centers
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Bodystat Ltd.
  • COSMED Srl
  • GE Healthcare
  • Hologic Inc.
  • Inbody Co. Ltd.
  • Omron Corporation
  • RJL Systems Inc.
  • Seca GmbH & Co. Kg.
  • SELVAS Healthcare
  • Tanita Corporation

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2514&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Alpha 1 Antitrypsin Deficiency Treatment Market Analysis 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Alpha 1 Antitrypsin Deficiency Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global alpha 1 antitrypsin deficiency treatment market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the alpha 1 antitrypsin deficiency treatment market?

Report Attributes Details
Market Size in 2022 US$ 1.9 Billion
Market Forecast in 2028 US$ 3.1 Billion
Growth rate (2023 to 2028) CAGR of 8.3%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is alpha 1 antitrypsin deficiency treatment?

Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder due to which the body does not generate sufficient AAT protein. AAT proteins protect the lungs and liver from the adverse effects of other proteins present in the body. Patients with AAT deficiency are prone to numerous medical ailments, including liver cirrhosis, chronic obstructive pulmonary diseases (COPD), etc. A genetic or blood test can detect the AAT protein deficiency, which can be further treated by pulmonary rehabilitation, augmentation, and oxygen therapy. Furthermore, treatment procedures mainly involve the administration of medicines, such as bronchodilators and corticosteroids.

Request for a free sample copy of this report:https://www.imarcgroup.com/alpha-1-antitrypsin-deficiency-treatment-market/requestsample

What are the growth prospects and trends in the alpha 1 antitrypsin deficiency treatment industry?

The rising occurrence of respiratory disorders, due to the increasing air pollution levels and high consumption of tobacco products, is primarily driving the market growth. Besides this, the widespread utilization of augmentation therapy for improving the recovery speed of patients, reducing the frequency of exacerbations, delaying emphysema progression, etc., is also driving the market. Moreover, several advancements in the diagnostic methods, along with the development of innovative processes for the production and purification of AAT, are further catalyzing the global market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Treatment Type:

  • Augmentation Therapy
  • Bronchodilators
  • Corticosteroids
  • Oxygen Therapy
  • Others

Breakup by Route of Administration:

  • Parenteral
  • Inhalation
  • Oral

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • AstraZeneca PLC
  • C.H. Boehringer Sohn AG & Ko. KG
  • CSL Limited
  • GlaxoSmithKline Plc
  • Grifols S.A., Kamada Ltd.
  • LFB Biomedicaments S.A.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2467&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Cardiovascular Information System Market 2023 Share, Size, Growth, Trends and Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled “Cardiovascular Information System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cardiovascular information system (CVIS) market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the cardiovascular information system market?

Report Attributes Details
Market Size in 2022 US$ 1,033.3 Million
Market Forecast in 2028 US$ 1715.9 Million
Growth rate (2023 to 2028) CAGR of 9.07%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is cardiovascular information system?

The cardiovascular information system (CVIS) refers to an advanced software solution that collects clinical information in the form of electronic medical records (EMR). It is used for echocardiography, hemodynamics monitoring, vascular ultrasound, electrophysiology, cardiac and peripheral catheterization, etc. CVIS stores the information in real-time across several locations, which is often used to evaluate cardiac diseases. This helps in streamlining workflows and minimizing errors, thereby enabling physicians to make rational therapeutic decisions.

Request for a free sample copy of this report:
https://www.imarcgroup.com/cardiovascular-information-system-market/requestsample

What are the growth prospects and trends in the cardiovascular information system industry?

The growing geriatric population, along with the rising prevalence of various cardiovascular disorders due to sedentary lifestyle habits, have led to an increasing demand for CVIS. Furthermore, the rapid digitization and constant developments in the healthcare information technology (IT) sector are also propelling the CVIS industry. The rising adoption rate of zero-footprint systems and increasing demand for remotely accessing medical data in healthcare facilities further fuel the market growth. The growing popularity of CVIS for enhancing the efficiency and interoperability of diagnostic centers is also driving the market. The increasing penetration of data-driven technologies and rising investments in R&D activities are anticipated to drive the cardiovascular information system market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • CVIS (Cardiovascular Information System)
  • C-PACS (Cardiology Picture Archiving and Communication System)

Breakup by Component:

  • Software
  • Hardware
  • Services

Breakup by Mode of Operation:

  • Web-based
  • Onsite
  • Cloud-based

Breakup by End-User:

  • Hospitals and Clinics
  • Cardiac Cath Labs
  • Diagnostic Centers
  • Others

Breakup by Application:

  • Catheterization
  • Echocardiography
  • Electrocardiogram
  • Electrophysiology
  • Nuclear Cardiology
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Agfa Healthcare India Private Limited
  • Cerner Corporation
  • Digisonics Inc.
  • Fujifilm Medical Systems
  • GE Healthcare
  • LUMEDX Corporation
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2127&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Array Instruments Market Growth 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global array instruments market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the array instruments market?

Report Attributes Details
Market Size in 2022 US$ 1.1 Billion
Market Forecast in 2028 US$ 1.4 Billion
Growth rate (2023 to 2028) CAGR of 3.2%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is array instruments?

Array instruments are devices that are used to collect microscopic spots of RNA, DNA, proteins, tissues, peptides, oligonucleotides, cells, and other compounds attached to a solid substrate. They are utilized in laboratories that quantitatively and simultaneously monitor the expression of multiple genes. The high-throughput approach of array technology helps to locate mutations and chromosomal expressions in a genotype, and measure and detect gene expressions at the messenger RNA (mRNA) or the protein level.

Request for a free sample copy of this report: https://www.imarcgroup.com/array-instruments-market/requestsample

What are the growth prospects and trends in the array instruments industry?

The primary factors driving the array instruments market are the emerging need for diagnosing cancer, post-natal and different metabolic diseases. These instruments assist in hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning, which have increased their demand in recent times. Furthermore, governments across the globe have undertaken several initiatives to improve the healthcare infrastructure and increase investments in research and development (R&D) activities, which in turn have boosted the demand for array instruments. Moreover, the introduction of the latest technologies, such as microarray-based comparative genomic hybridization, has enhanced the process of single nucleotide polymorphism (SNP) and offers accuracy and precision in disease diagnosis and drug discovery, which in turn is expected to provide a positive impact on the industry.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Application:

  • Molecular Biology
  • Cell Biology
  • Genetics
  • Molecular Pathology
  • Others

Breakup by Technology:

  • DNA Microarrays
  • Protein Microarrays
  • Cellular Microarrays
  • Tissue Microarrays

Breakup by End-User:

  • Research and Development Laboratories
  • Clinical Diagnostic Labs
  • Agriculture Research Centers
  • Veterinary Laboratories
  • Forensic Centers
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Arrayit Corporation
  • Bio-RAD Laboratories Inc.
  • Illumina Inc.
  • Laboratory Corporation
  • Molecular Devices LLC
  • Raybiotech Inc.
  • Sigma Aldrich Corporation
  • Thermo Fisher Scientific Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2080&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Waste Heat Recovery Boiler Market 2023 Share, Size, Growth | Forecast 2028

IMARC Group, a leading market research company, has recently releases report titled “Waste Heat Recovery Boiler Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global waste heat recovery boiler market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the waste heat recovery boiler market?

Report Attributes Details
Market Size in 2022 US$ 7 Billion
Market Forecast in 2028 US$ 9.9 Billion
Growth rate (2023 to 2028) CAGR of 5.9%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is waste heat recovery boiler?

A waste heat recovery boiler is a system that is used for minimizing the wastage of heat generated by industrial plants. It captures the heat dissipating from industrial processes for reuse in other heating applications, like power generation. The waste heat recovery boiler is used by factories that produce steel, cement, non-ferrous metals and chemicals, like ethylene, ammonia, sulfuric acid, and nitric acid.

Request Free Sample Report: https://www.imarcgroup.com/waste-heat-recovery-boiler-market/requestsample

What are the growth prospects and trends in the waste heat recovery boiler industry?

The need for enhanced energy-efficient industrial processes is the primary factor driving the waste heat recovery boiler market. The significant growth in the power, oil, and gas industries has also escalated the demand for these boilers as they are utilized for removing heat from a process fluid that needs to be cooled down for transportation or storage. Furthermore, the growing demand for continuous electricity supply has encouraged governments to increase investments in cleaner technologies, such as waste heat recovery boilers, which emit minimal greenhouse gases. These factors are expected to have a positive impact on the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • Water Tube Boiler
  • Fire Tube Boiler

Breakup by Waste Heat Temperature:

  • Medium Temperature
  • High Temperature
  • Ultra-High Temperature

Breakup by Waste Heat Source:

  • Oil Engine Exhaust
  • Gas Engine Exhaust
  • Gas Turbine Exhaust
  • Incinerator Exit Gases
  • Others

Breakup by Orientation:

  • Horizontal
  • Vertical

Breakup by End-Use Industry:

  • Power Generation Utilities
  • Oil & Gas
  • Chemical
  • Primary Metals
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Alfa Laval
  • Amec Foster Wheeler
  • Robert Bosch
  • Forbes Marshall
  • General Electric
  • Nooter/Eriksen
  • Siemens
  • Thermax
  • Thyssenkrupp
  • Viessmann
  • Zhengzhou Boiler

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2138&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Rehabilitation Robots Market Growth 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Rehabilitation Robots Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global rehabilitation robots market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the rehabilitation robots market?

Report Attributes Details
Market Size in 2022 US$ 1,071 Billion
Market Forecast in 2028 US$ 3,428 Billion
Growth rate (2023 to 2028) CAGR of 21.5%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is rehabilitation robots?

Rehabilitation robots are automated therapy machines that assist individuals in performing physical movements while interacting with their surroundings. These robots utilize input devices, sensors, and actuators to balance body weight and control motion, speed, direction, amplitude, coordination patterns, etc. Rehabilitation robots record movement data that is utilized by healthcare professionals to alter therapy intensity and provide quality care. Furthermore, they aim to deliver customized, task-oriented, prolonged, intensive, standardized, and repeatable training. As a result, rehabilitation robots are generally used for treating patients suffering from stroke, multiple sclerosis, traumatic brain injury (TBI), spinal cord injury, Parkinson’s disease, etc.

Request for a free sample copy of this report:
https://www.imarcgroup.com/rehabilitation-robots-market/requestsample

What are the growth prospects and trends in the rehabilitation robots industry?

The rising geriatric population who are more prone to chronic medical conditions leading to complete or partial loss of body movements, is primarily driving the demand for rehabilitation robots. Additionally, the integration of voice-recognition algorithms to enhance the functionality and flexibility of the devices is also escalating the demand for these robots. Furthermore, the rapid incorporation of Internet-of-Things (IoT) with rehabilitation robotics to enable assessment and treatment of patients over the internet is also catalyzing the market growth. Moreover, the growing investments by several manufacturers in developing lightweight products and integrating virtual reality (VR) and video games to improve patient motivation are further augmenting the market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

  • Therapeutic Robots
  • Exoskeleton Robots
  • Assistive Robots
  • Others

Breakup by Patient Type:

  • Adult
  • Pediatric

Breakup by End User:

  • Rehabilitation Centers
  • Hospitals
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Bionik Laboratories Corp.
  • Ekso Bionics Holdings Inc.
  • Hocoma AG (DIH International Ltd.)
  • Kinova Inc.
  • KUKA Aktiengesellschaft (Midea Group)
  • Parker-Hannifin Corporation
  • Rehab-Robotics Company Limited
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd.
  • Siemens Aktiengesellschaft
  • Tyromotion GmbH

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2384&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Resistant Starch Market Growth 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Resistant Starch Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global resistant starch market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the resistant starch market?

Report Attributes Details
Growth rate (2023 to 2028) CAGR of 6.8%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is resistant starch?

Resistant starch refers to a naturally occurring carbohydrate found in beans, lentils, peas, whole grains, cooked rice, and plantains. This starch resists the digestion process in the small intestine and instead ferments in the large intestine and also acts as a prebiotic to increase healthy bacteria in the gut. Resistant starch minimizes fat storage, lowers triglyceride concentration, improves satiety, and enhances insulin sensitivity. The moderate consumption of resistant starch reduces colon cancer risk and decreases cholesterol levels. The rising demand for organic food products primarily drives the market for resistant starch worldwide.

Request for a free sample copy of this report: https://www.imarcgroup.com/resistant-starch-market/requestsample

What are the growth prospects and trends in the resistant starch industry?

The extensive utilization of resistant starch in the food and beverages industry is augmenting the product demand. It is used as a texturizer, thickener, and stabilizer in pasta, noodles, bread, ice-creams, cookies, custards, etc. Furthermore, growing consumer preferences for gluten-free and low carbohydrate ready-to-eat (RTE) food products are also bolstering the market growth. Moreover, resistant starch finds extensive applications in the agricultural sector to improve crop yields’ nutritional content and enhance crop productivity.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Source:

  • Vegetables
  • Grains
  • Fruits
  • Nuts
  • Others

Breakup by Process:

  • Biotechnology
  • Mutation
  • Natural Source
  • Others

Breakup by Application:

  • Bakery Products
  • Confectionery
  • Breakfast Cereals
  • Dairy Products
  • Others

Breakup by Geography:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Arcadia Biosciences Inc.
  • Cargill Incorporated
  • Gut Garden LLC
  • Ingredion Incorporated
  • MGP Ingredients Inc.
  • Natural Stacks Inc.
  • Roquette Freres
  • Tate & Lyle Plc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3392&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Fish Protein Hydrolysate Market Growth 2023-2028, Industry Size, Share, Trends and Forecast

IMARC Group, a leading market research company, has recently releases report titled “Fish Protein Hydrolysate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global fish protein hydrolysate market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the fish protein hydrolysate market?

Report Attributes Details
Market Size in 2022 US$ 304.7 Million
Market Forecast in 2028 US$ 404.5 Million
Growth rate (2023 to 2028) CAGR of 4.7%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What is fish protein hydrolysate?

Fish protein hydrolysate (FPH) refers to a bioactive compound produced by utilizing decomposed fish proteins. The compound is obtained by decomposing minced fish meat with enzymes, such as trypsin, pepsin, and chymotrypsin to break down the proteins into peptides and amino acids. Both salt and freshwater fishes, including anchovy, crustacean, tuna, salmon, and sardine, can be used to produce FPH. It acts as a rich source of fatty acids, which helps in maintaining cardiovascular health and blood pressure levels. FPH is typically used as a food binder, gelling agent, nutritional supplement, emulsifier, etc.

Request for a free sample copy of this report: https://www.imarcgroup.com/fish-protein-hydrolysate-market/requestsample

What are the growth prospects and trends in the fish protein hydrolysate industry?

The growing pharmaceutical industry worldwide is the primary factor driving market growth. Several health benefits associated with FPH, such as minimizing the risk of hypertension and developing lean muscle mass, have led to its utilization in sports nutrition and protein supplements. Furthermore, FPH is also used as an alternative hypoallergenic protein for infants suffering from glucose and lactose intolerance and treating Crohn’s Disease and Irritable Bowel Syndrome. Additionally, rising disposable income levels and the growing use of FPH in cosmetics for its anti-aging properties are further augmenting the global market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Technology:

  • Acid Hydrolysis
  • Autolytic Hydrolysis
  • Enzymatic Hydrolysis

Breakup by Form:

  • Liquid
  • Powder

Breakup by Fish Type:

  • Anchovy
  • Herrings
  • Menhaden
  • Sardine
  • Shads
  • Others

Breakup by Application:

  • Food
  • Pharmaceuticals
  • Animal Feed and Pet Food
  • Cosmetics
  • Others

Who are the key players operating in the industry?

The report covers the major market players including:

  • Alaska Protein Recovery LLC
  • Bio-marine Ingredients Ireland Ltd.
  • Copalis
  • Dramm Corporation
  • Gelita AG
  • Great Pacific BioProducts Ltd.
  • Hofseth Biocare ASA
  • Janatha Fish Meal & Oil Products
  • SAMPI
  • Scanbio Marine Group AS
  • Symrise AG
  • United Fisheries Ltd.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3384&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/